Inquirer Technology on MSN3d
US approves 1st fast-acting insulin biosimilar for diabetes
The US Food and Drug Administration approved the first-ever rapid-acting insulin for reducing blood sugar levels. It calls ...
The Healthy on MSN4d
More Than 900,000 Diabetes Devices Have Been Recalled Nationwide
According to 2021 data from the American Diabetes Association, 2 million Americans have type 1 diabetes—304,000 of which are ...
MPR12d
FDA Approves Merilog, a Rapid-Acting Insulin Biosimilar Product
Insulin-aspart-szjj is the first rapid-acting insulin biosimilar approved and the third insulin product approved by the FDA.
Medscape10d
Automated Insulin Delivery Tech Okayed for Type 2 Diabetes
Tandem Diabetes Care, Inc.’s Control-IQ+ Technology, used with the t:slim and Mobi insulin pumps, becomes the second AID ...
California Made a Big Bet on Producing Its Own Insulin, But There’s No ‘Date Certain’ for Delivery
During a hearing, representatives for the Newsom administration said they could not provide a timeline for when ...
6 Benefits of Metformin (Besides Weight Loss)
Metformin is the most commonly prescribed oral drug for diabetes. Of course, if you or a loved one receives treatment for ...
Down 39%. Is Novo Nordisk Stock a Buy on the Dip?
Despite falling hard since last summer, shares of Novo Nordisk have more than doubled the market's overall performance. The ...
The Punch on MSN3d
NAFDAC alerts Nigerians on circulation of substandard insulin syringes
The National Agency for Food and Drug Administration and Control has raised the alarm over the illegal circulation and ...
Trump’s pick to lead FDA tells senators he’d look into food, abortion pill, vaccine advisers
President Donald Trump’s pick to lead the US Food and Drug Administration told senators in a tense confirmation hearing ...
Biocon Biologics to supply Insulin Aspart drug substance to Civica for US market
Biocon Biologics partners with Civica to enhance access to Insulin Aspart in the US, no tech transfer involved.
Takeways: Trump’s FDA nominee breezes through confirmation hearing
Dr. Marty Makary, Trump's nominee for FDA Commissioner, breezed through his confirmation hearing despite tough questions from Democrats and Republicans.